SCICONX Journal of Pharmaceutical Chemistry & Biopharmaceutics

The SCICONX Journal of Pharmaceutical Chemistry and Biopharmaceutics (JPCB) is a premier, international, peer-reviewed, open-access platform dedicated to publishing cutting-edge research in pharmaceutical sciences, chemistry, and biopharmaceutics. Our journal aims to foster innovation, collaboration, and knowledge dissemination among scientists, clinicians, and industry professionals engaged in advancing drug discovery, formulation, and therapeutic technologies.

✦ About JPCB

JPCB serves as a comprehensive resource for researchers, academics, and practitioners in pharmaceutical chemistry and biopharmaceutics. The journal emphasizes high-quality research that bridges the gap between fundamental science, applied drug development, and clinical therapeutics. By integrating studies from molecular design to advanced drug delivery systems, JPCB highlights interdisciplinary approaches that drive the future of healthcare.

Our mission is to support the global scientific community by providing a transparent, rigorous, and ethical platform for publishing research that can enhance drug efficacy, safety, and patient outcomes. We prioritize work that contributes to scientific knowledge, encourages innovation, and fosters collaborations across pharmaceutical research and development.

✦ Scope and Focus Areas

JPCB publishes original research, comprehensive reviews, short communications, and case studies in areas including, but not limited to:

• Pharmaceutical Chemistry: Design, synthesis, and characterization of novel pharmaceutical compounds.
• Biopharmaceutics: Studies on drug absorption, distribution, metabolism, excretion, and bioavailability.
• Drug Delivery Systems: Advanced formulations, Nano-pharmaceutics, targeted delivery, and controlled-release technologies.
• Pharmacokinetics & Pharmacodynamics: Insights into drug interactions, therapeutic efficacy, and safety profiles.
• Analytical and Computational Methods: Techniques in drug analysis, molecular modelling, QSAR, and chemoinformatics.
• Regulatory Science & Quality Control: Stability studies, good manufacturing practices, and clinical compliance.
• Emerging Trends: Personalized medicine, biopharmaceutical innovations, and translational drug development.

By covering this diverse spectrum, JPCB ensures that readers access the latest developments in pharmaceutical science and biopharmaceutics.

✦ Why Publish with JPCB?

1. High Visibility: As an open-access journal, all published articles are freely available worldwide, ensuring maximum visibility and impact.
2. Rigorous Peer Review: Every submission undergoes a double-blind peer review process conducted by experts in the field, ensuring scientific accuracy and credibility.
3. Rapid Publication: We provide efficient manuscript handling, from submission to online publication, without compromising quality.
4. Global Collaboration: Our journal welcomes contributions from researchers, academicians, and industry professionals worldwide.
5. Ethical Standards: JPCB strictly adheres to COPE and ICMJE guidelines, promoting transparency, integrity, and responsible research practices.

✦ Who Should Read JPCB?

JPCB is an essential resource for:

• Pharmaceutical chemists and biochemists.
• Formulation scientists and pharmacologists.
• Clinicians and healthcare researchers interested in drug therapy.
• Regulatory professionals and quality assurance specialists.
• Graduate students, postdoctoral researchers, and academics in pharmaceutical sciences.

✦ Editorial Vision

Our editorial board comprises globally recognized experts committed to maintaining the highest standards of academic publishing. JPCB continuously seeks to highlight innovative research that contributes to the advancement of pharmaceutical science, improves drug development strategies, and ultimately enhances patient care.

✦ Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

✦ Join the JPCB Community

Whether you are submitting a manuscript, reviewing research, or exploring the latest discoveries, JPCB provides a dynamic, authoritative, and inclusive platform for knowledge exchange in pharmaceutical chemistry and biopharmaceutics.

Discover, publish and collaborate with JPCB - shaping the future of pharmaceutical innovation.